Cite
HARVARD Citation
Yoo, B. et al. (2020). Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years. Human vaccines & immunotherapeutics. 16 (6), pp. 1260-1267. [Online].